Tomas Odergren

Chief Tech/Sci/R&D Officer at BIOARCTIC AB

67 year

Health Technology

Consumer Services

Commercial Services

Profile

Dr. Tomas Odergren is a Chief Medical Officer at BioArctic AB and a Chairman at NovaSAID AB. Dr. Odergren was previously employed as a Vice President-Clinical Development by Karolinska Development AB, a Principal by AstraZeneca GmbH, and a Non-Executive Director by BioChromix Pharma AB. He also served on the board at Athera Biotechnologies AB, Forendo Pharma Oy, Modus Therapeutics AB, Modus Therapeutics Holding AB and Umecrine Cognition AB. He received his doctorate degree from Karolinska Institutet.

Tomas Odergren active positions

Companies	Position	Start
BIOARCTIC AB	Chief Tech/Sci/R&D Officer	01/01/2019
NovaSAID AB NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis	Chairman	-

All active positions of Tomas Odergren

Former positions of Tomas Odergren

Companies	Position	End
KDVENTURES AB	Chief Tech/Sci/R&D Officer	01/11/2014
AstraZeneca GmbH AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs	Corporate Officer/Principal	12/10/2012
Umecrine Cognition AB Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain	Director/Board Member	-
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Director/Board Member	-
Modus Therapeutics AB Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease	Director/Board Member	-

See the detail of Tomas Odergren's experience

Training of Tomas Odergren

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tomas Odergren's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Athera Biotechnologies AB Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs	Health Technology
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BioArctic AB BioArctic AB Pharmaceuticals: MajorHealth Technology Develops drugs for patients with disorders of the central nervous systems	Health Technology
AstraZeneca GmbH AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs	Health Technology
BioChromix Pharma AB BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides Alzheimer disease research services	Commercial Services
Umecrine Cognition AB Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain	Health Technology
NovaSAID AB NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis	Health Technology
Karolinska Development AB Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company	Finance
Modus Therapeutics AB Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease	Health Technology
Modus Therapeutics Holding AB Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease	Health Technology
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Health Technology